- Home
- Feed
- Meat
- Pork
- Poultry
- Countries
- China News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- India News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Indonesia News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Malaysia News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Philippines News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Singapore News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Thailand News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Vietnam News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Home
- Feed
- Meat
- Pork
- Poultry
- Countries
- China News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- India News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Indonesia News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Malaysia News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Philippines News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Singapore News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Thailand News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
- Vietnam News
UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...
Sign in as a member, or Join our Community for free to unlock the full article.
ASIAN AGRIBUSINESS MEDIA PTE LTD